Why the study?
How should venous thromboembolism be diagnosed and managed in patients with neurologic and neurosurgical diseases?
How should venous thromboembolism be diagnosed and managed in patients with neurologic and neurosurgical diseases?
This review highlights the high risk of VTE in neurologic patients and emphasizes the need for high clinical suspicion and appropriate anticoagulation management.
Answers are grounded in this paper and cite their sources.
High VTE risk in neurologic patients supports anticoagulation when bleeding risk is acceptable; leaves open prospective validation of protocols.
Patients with neurologic disease are at high risk of venous thromboembolism (VTE) (deep venous thrombosis [DVT] or pulmonary embolism [PE]) because of relative immobility or an increased risk of hypercoagulable states. Patients with spinal cord injuries, brain tumors, and strokes are at particularly high risk for VTE. Well-established risk assessment tools and a number of well-defined diagnostic tests to establish a VTE diagnosis are available. Unfortunately, physicians, in both the inpatient and outpatient settings, often do not have a sufficiently high level of clinical suspicion for DVT or PE, and the diagnosis is sometimes missed. The treatment of VTE is anticoagulation unless the patient is at unacceptably high risk for serious bleeding complications. The duration of anticoagulation depends on the presence of underlying hypercoagulable states and a prior history of VTE.
No takes yet. Share an insight, caveat, or question.
Schneck et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: